| Compd. No. | Dose (Molar) | Anti-HIV-1 Activity | |||
| IC50 (μg/mL) | Max Production % | Percent of Control | |||
| 2. 00 × 10−6 |
|
| Infected | Uninfected | |
| 3 | >55.13 | 13.5 | 10.11 | 101.11 | |
| 6 | >20.20 | 19 | 17.38 | 106.32 | |
| 7 | >27.20 | 26.5 | 63.51 | 97.93 | |
| 10 | >19. 40 | 30.5 | 80.29 | 96.11 | |
| 12 | >28.57 | 25.0 | 35.40 | 105.77 | |
| 14 | >88.30 | 9.5 | 0.04 | 0.51 | |
| 16 | >3.99 | 16.00 | 14.16 | 101.91 | |
| 18 | >42.60 | 35.00 | 83.47 | 104.97 | |
| 22 | >94.40 | 23.5 | 18.19 | 104.12 | |